Search Results - "Dabbous, O."

Funding breakthrough therapies: A systematic review and recommendation by Hanna, E., Toumi, M., Dussart, C., Borissov, B., Dabbous, O., Badora, K., Auquier, P.

“…•Funding models were classified into: financial agreement, health outcomes-based agreement and healthcoin.•National silo funds were considered the most…”
Get full text

Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) by Fox, K A A, Anderson, F A, Dabbous, O H, Steg, P G, López-Sendón, J, Van de Werf, F, Budaj, A, Gurfinkel, E P, Goodman, S G, Brieger, D

“…Objective: To determine whether revascularisation is more likely to be performed in higher-risk patients and whether the findings are influenced by hospitals…”
Get full text

Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events by Nallamothu, B, Fox, K A A, Kennelly, B M, Van de Werf, F, Gore, J M, Steg, P G, Granger, C B, Dabbous, O H, Kline-Rogers, E, Eagle, K A

“…Objective:Treatment delays may result in different clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) who receive…”
Get full text

Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE) by Fox, K. A. A., Goodman, S. G., Klein, W., Brieger, D., Steg, P. G., Dabbous, O., Avezum, Á.

“…Aims Despite advances in the treatment of acute coronary syndromes based on randomized trial data and published guidelines, the extent to which such treatments…”
Get full text

Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE) by Carruthers, K F, Dabbous, O H, Flather, M D, Starkey, I, Jacob, A, MacLeod, D, Fox, K A A

“…Objective: To determine to what extent evidence based guidelines are followed in the management of acute coronary syndromes (ACS) in the UK, elsewhere in…”
Get full text

T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation by Hohnloser, SH, Ikeda, T, Bloomfield, DM, Dabbous, OH, Cohen, RJ

“…In a trial of prophylactic implantation of a defibrillator, a mortality benefit was seen among patients with previous myocardial infarction and a…”
Get full text

Progression Of Vision Loss In Patients With Geographic Atrophy- A Disease Model by Arjunji, R, Wang, F, Gutierrez, B, Bhattacharyya, A, Alfonso, R, Williams, R, Dabbous, O

Get full text

Empirical Estimation Of Statistical Power And Minimum Number Of Studies Needed For A Network Meta-Analysis by Parks, D.C, Lee, K, Dabbous, O, Lin, X, Cockle, S, Stanford, R, Alfonso-Cristancho, R

Get full text

Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy by Nelson, S P, Kothari, S, Wu, E Q, Beaulieu, N, McHale, J M, Dabbous, O H

“…To describe the incidence of diagnosis of gastroesophageal reflux disease and acid-related conditions (GERD/ARC) throughout childhood and characterize patterns…”
Get more information

The development and validation of a Nocturnal Gastro‐oesophageal Reflux Disease Symptom Severity and Impact Questionnaire for adults by Spiegel, B. M., Roberts, L., Mody, R., Harding, G., Kothari‐Talwar, S., Kahrilas, P. J., Camilleri, M. L., Dabbous, O., Revicki, D. A.

“…Aliment Pharmacol Ther 2010; 32: 591–602 Summary Background  Current questionnaires for assessing gastro‐oesophageal reflux disease (GERD) symptoms are limited…”
Get full text

Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry by Devlin, G, Anderson, F A, Heald, S, López-Sendón, J, Avezum, Á, Elliott, J, Dabbous, O H, Brieger, D

“…Objective: To document patterns of risk stratification, management practices, and outcomes among patients with acute coronary syndromes (ACS) presenting…”
Get full text

Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer’s Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers? by Messner, Donna A., Rabins, P., Downing, A. C., Irizarry, M., Foster, N. L., Al Naber, J., Dabbous, O., Fillit, H., Gabler, S., Krakauer, R., Lotz, D., Payzant, E., Schneider, L., Tyrone, J., Van Amerongen, D., Wuest, D.

“…Background Drug development for disease modifying agents in Alzheimer’s disease (AD) is focused increasingly on targeting underlying pathology in very early…”
Get full text

PDB56 Development and Validation of Patient Reported Endpoints for T2DM by Bron, M, Hudgens, S, Stokes, J, Banderas, B, Viswanathan, P, Dabbous, O

Get full text

Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors by Kothari, S., Nelson, S.P., Wu, E.Q., Beaulieu, N., McHale, J.M., Dabbous, O.H.

“…Abstract Background: Gastroesophageal reflux disease and acid-related conditions (GERD/ARC) are common in pediatric practice but their costs have not been well…”
Get full text

Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes by Dabbous, O H, Anderson, Jr, F A, Gore, J M, Eagle, K A, Fox, K A A, Mehta, R H, Goldberg, R J, Agnelli, G, Steg, P G

“…To compare the characteristics, management, and outcomes of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) who would have been…”
Get more information

165P Health Care Resource Use (HCRU) for patients with spinal muscular atrophy (SMA) Types 2 or 3 in the UK by Reyna, S., Toro, W., Patel, A., Saleh, S., Dabbous, O.

“…Data on HCRU for patients with SMA types 2 (SMA2) and 3 (SMA3) are sparse. To our knowledge, no studies address costs from the HCP perspective. We assessed…”
Get full text

PT42 The Impact of Spinal Muscular Atrophy Type 2 on Caregivers in Argentina: Results of a Global Survey by Patel, A., Toro, W., Esquerro, M.E., Dabbous, O.

Get full text

RWD164 The Impact of Spinal Muscular Atrophy (SMA) Type 1 on Caregivers in Taiwan: Results of a Global Survey by Patel, A., Yang, K., Toro, W., Dabbous, O., Jong, Y.J.

Get full text

Determinants and prognostic impact of heart failure complicating Acute Coronary Syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE) by STEG, Philippe Gabriel, DABBOUS, Omar H, FELDMAN, Laurent J, COHEN-SOLAL, Alain, AUMONT, Marie-Claude, LOPEZ-SENDON, José, BUDAJ, Andrzej, GOLDBERG, Robert J, KLEIN, Werner, ANDERSON, Frederick A

“…Few data are available on the impact of heart failure (HF) across all types of acute coronary syndromes (ACS). The Global Registry of Acute Coronary Events…”
Get full text

EE462 Value-Based Pricing for Patent-Protected Medicines: Pricing Anomalies in the "Age of Cures” and Their Implications for Dynamic Efficiency by Garrison, LP, Jiao, B, Dabbous, O

Get full text